As of Apr 16, 2018 Castlight Health Inc Class B (NYSE:CSLT) Sellers Declined Their Shorts By 5.88%

April 16, 2018 - By Mary Markley

Castlight Health, Inc. (NYSE:CSLT) Corporate Logo

Big Money Sentiment decreased to 1.23 in Q4 2017. It has change of 0.82, from 2017Q3’s 2.05. The ratio turned negative due to Castlight Health, Inc. positioning: 10 sold and 21 reduced. 16 funds acquired holdings and 22 increased holdings. Investors holded 44.86 million in 2017Q3 but now own 46.25 million shares or 3.11% more.
Moreover, Gagnon Ltd Limited Liability Company has 1.96% invested in Castlight Health, Inc. (NYSE:CSLT). Needham Inv Mgmt Ltd Liability Company has 75,000 shs for 0.07% of their capital. Alliancebernstein Lp holds 0% or 92,750 shs. Moreover, Fincl Bank Of New York Mellon Corporation has 0% invested in Castlight Health, Inc. (NYSE:CSLT) for 544,013 shs. Deutsche State Bank Ag has 0% invested in Castlight Health, Inc. (NYSE:CSLT) for 142,486 shs. Texas-based Dimensional Fund Advisors L P has invested 0% in Castlight Health, Inc. (NYSE:CSLT). Schwab Charles Mngmt has invested 0% in Castlight Health, Inc. (NYSE:CSLT). 10,000 are held by Budros Ruhlin & Roe. Tiaa Cref Inv Management Ltd Liability owns 164,584 shs. The Switzerland-based Swiss Bancshares has invested 0% in Castlight Health, Inc. (NYSE:CSLT). New York State Common Retirement Fund has invested 0% of its capital in Castlight Health, Inc. (NYSE:CSLT). Metropolitan Life Ins Communication holds 12,135 shs or 0% of its capital. California Pub Employees Retirement Systems invested in 0% or 42,400 shs. Morgan Stanley reported 0% in Castlight Health, Inc. (NYSE:CSLT). Ameritas Investment stated it has 0% of its capital in Castlight Health, Inc. (NYSE:CSLT).

Castlight Health, Inc. registered $120,817 net activity with 0 buys and 4 selling transactions since February 15, 2018. On Thursday, February 15 Nolan Mangini Siobhan also sold $3,741 worth of Castlight Health, Inc. (NYSE:CSLT).

Change of 5.88% for Castlight Health Inc Class B (NYSE:CSLT)’s short interest was recorded. FINRA issued short interest of CSLT’s total 4.28 million shares. The down change of 5.88% from 4.55M shares was reported. With Average volume 432,600, CSLT’s previous position will take 10 days to recover. Castlight Health Inc Class B float short is 7.04%.

Its shares touched $3.47 on during the last trading session after 2.21% change.Currently Castlight Health, Inc. is uptrending after 6.15% change in last April 16, 2017. CSLT has 162,501 shares volume. The stock underperformed the S&P500 by 5.40%.

Castlight Health, Inc. operates a health benefits platform in the United States.The firm is valued at $470.08 million. The companyÂ’s platform engages employees to make better health decisions and enables employers to communicate and measure their benefit programs.Currently it has negative earnings. The Company’s platform also provides real-time insight into employee engagement with benefits and programs enabling employers to monitor and adjust their strategies.

Castlight Health, Inc. (NYSE:CSLT) Ratings Coverage

In total 4 analysts cover Castlight Health (NYSE:CSLT). “Buy” rating has 3, “Sell” are 1, while 0 are “Hold”. 75% are bullish. 7 are the (NYSE:CSLT)’s analyst reports since October 25, 2017 according to StockzIntelligence Inc. On Thursday, October 26 Chardan Capital Markets maintained Castlight Health, Inc. (NYSE:CSLT) with “Buy” rating. On Monday, November 6 the stock of Castlight Health, Inc. (NYSE:CSLT) has “Hold” rating given by Cantor Fitzgerald. On Thursday, October 26 Stifel Nicolaus maintained Castlight Health, Inc. (NYSE:CSLT) with “Buy” rating. On Wednesday, January 31 the rating was upgraded by Cantor Fitzgerald to “Overweight”. On Wednesday, February 21 the company was maintained by Cantor Fitzgerald.

Castlight Health, Inc. (NYSE:CSLT) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: